Back to Polls Poll Results

Poll Results


Which insulins do you or your child use?


Vote for all that apply


Short acting insulins




















Long acting insulins




























Premixed (70/30, etc.)






Other insulin






Don't use insulin






Total votes: 996


Which insulins do you or your child use?

Poll dates: January 18 - 25, 2004
Total Votes: 996

Insulin users today have a great variety of products from which to choose. In the past few years, two fast-acting analogs (Humalog and NovoLog) and one long-acting analog (Lantus) have been introduced and have changed the way many people use insulin. The use of Regular insulin among our readers has dropped off to two percent. NPH use has dropped too, from 32% in 2000 to 16% in 2004.

This table shows readers' answers to this survey over the past four years:

  Answer     Jan 2004     Jan 2003     Jan 2002     Mar 2000  
Short acting insulins
Humalog 26% 34% 37% 35%
NovoLog 26% 12% 3% --
Regular 2% 3% 4% 12%
Long acting insulins
NPH 16% 22% 28% 32%
Lente 1% 1% 3% 4%
Ultralente 1% 2% 5% 7%
Lantus 21% 17% 11% --
Premixed 1% 2% 2% 5%
Other insulin 1% 2% 2% 2%
Percentages based on use compared with all responses

Looking at answers in the short-acting and long-acting insulins shows a dramatic change since 2000. The following graphs illustrate the rapid increase in use of insulin analogs and the concurrent decline in the use of Regular and NPH.

Rapid Acting Insulin Use

The rise in the use of NovoLog has been particularly significant since it was introduced in 2002. The use of Regular continues to decline. Among users of rapid-acting insulin, NovoLog and Humalog have essentially equal market share as of January 2004, at least among visitors to this web site.

Graph. Click for larger view.
Data within rapid-acting insulin only

Graph. Click for larger view.
Data among all responses

Long Acting Insulin Use

In 2004, for the first time, more people report using Lantus than NPH as their long-acting insulin. The use of Lente and Ultralente have declined to almost none. Lantus now shows greater than a 50% market share among users of long-acting insulin.

Graph. Click for larger view.
Data within long-acting insulin only

Graph. Click for larger view.
Data among all responses

[Download an Excel spreadsheet with the data and graphs from this poll]

[Return to the current poll]

  Home Return to Top

Last Updated: Wednesday March 16, 2005 16:37:42
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.